Insights Into Astrazeneca Q1: Wall Street Projections for Key Metrics - AstraZeneca (NASDAQ:AZN)

Benzinga

Center

High Factuality

Insights Into Astrazeneca Q1: Wall Street Projections for Key Metrics - AstraZeneca (NASDAQ:AZN)

In its upcoming report, Astrazeneca (NYSE: AZN) is predicted by Wall Street analysts to post quarterly earnings of $0.95 per share, reflecting a decline of 1% compared to the same period last year. Revenues are forecasted to be $11.94 billion, representing a year-over-year increase of 9.7%.